Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
FGF
>>
Phase 2
All trials
Active industry trials
Active owner-sponsored trials
Active trials
Export
Download options
Which format:
PDF
Excel Chart
TSV
Phase
N/A
1
2
3
4
Trials
0
2
4
6
8
10
12
14
16
18
20
thrombospondin-1 mimetic
(ABT-510) / AbbVie
aldafermin
(NGM282) / NGM Biopharma
pegbelfermin
(BMS-986036) / BMS
NN9500
/ Novo Nordisk
Max-40279
/ Maxinovel
ENMD-2076
/ CASI
tasurgratinib
(E7090) / Eisai
HMPL-453
/ Hutchmed
recifercept
(TA-46) / Pfizer
sprifermin
(AS-902330) / TrialSpark
ESK981
/ Esanik Therap
HA121-28
/ CSPC Pharma
gunagratinib
(ICP-192) / InnoCare
FP-1039
/ Amgen
RG7444
/ Roche
fazpilodemab
(BFKB8488A) / Roche
umedaptanib pegol
(RBM-007) / RIBOMIC
vofatamab
(B-701) / Rainier Therap
Aphthasol
(amlexanox) / Abeona Therap, Esteve
DVC1-0101
/ I’rom Group, Shenzhen Salubris
HST 001
/ Histogen
MK-3655
/ Merck (MSD)
TTHX1114 intracameral injection
/ Trefoil Therapeutics
TYRA-300
/ Tyra Biosci
fisogatinib
(BLU-554) / Blueprint Medicines
irpagratinib
(ABSK011) / Abbisko
zoligratinib
(Debio 1347) / Debiopharm
BOS-580
/ Boston Pharma
HH185
/ CSPC Pharma, HaiHe Biopharma
IONIS-FGFR4Rx
/ Ionis
LY3053102
/ Eli Lilly
SAR442501
/ Sanofi
SUN13837
/ Daiichi Sankyo
SYHA1815
/ CSPC Pharma
ZSP1603
/ Guangdong Zhongsheng Pharma
lirafugratinib
(RLY-4008) / Relay Therap
oleandrin
(PBI-05204) / Phoenix Biotech
roblitinib
(FGF401) / Everest Medicines
simmitinib
(SYHA1817) / CSPC Pharma
FPI-1966
/ AstraZeneca
R3Mab
/ Roche
S-49076
/ Servier
lenalidomide
(STAR-LLD SC) / Starton Therap
